Valuation: EBOS Group Limited

Market Cap 352.62Cr 247.75Cr 220.77Cr 204.39Cr 184.97Cr 348.49Cr 23TCr 2.45TCr 961.59Cr 12TCr 929.38Cr 910.03Cr 39TCr P/E 2027 *
15.1x
P/E 2028 * 13.1x
Enterprise Value 453.91Cr 318.91Cr 284.18Cr 263.11Cr 238.1Cr 448.59Cr 30TCr 3.15TCr 1.24TCr 16TCr 1.2TCr 1.17TCr 50TCr EV / Sales 2027 *
0.32x
EV / Sales 2028 * 0.31x
Free-Float
90.79%
Yield 2027 *
5.53%
Yield 2028 * 6.09%
1 day+16.99%
1 week+16.99%
Current month-1.29%
1 month-1.29%
3 months-11.54%
6 months-12.94%
Current year-34.34%
1 week 23
Extreme 23
23
1 month 19.66
Extreme 19.66
23
Current year 19.66
Extreme 19.66
46.64
1 year 19.66
Extreme 19.66
46.64
3 years 19.66
Extreme 19.66
47.23
5 years 19.66
Extreme 19.66
47.23
10 years 19.66
Extreme 19.66
47.23
Manager TitleAgeSince
Chief Executive Officer 51 01/07/2025
Director of Finance/CFO - 30/09/2024
Chief Tech/Sci/R&D Officer - 05/08/2024
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 01/07/2019
Director/Board Member 60 01/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+16.99%+16.99% - - 248.45Cr
+2.97%+4.46%+60.93%+126.73% 1,13300Cr
+2.36%+4.09%+36.64%+74.14% 62TCr
-0.07%+0.37%+24.39%+96.54% 50TCr
-0.26%+2.84%+39.22%+64.39% 38TCr
+1.94%+5.26%+74.44%+47.88% 37TCr
+1.75%+2.53%+23.10%+52.76% 29TCr
+2.14%+1.40%+2.68%+27.49% 26TCr
+1.83%+3.11%+51.20%+63.90% 24TCr
+1.36%-0.65%+28.72%+101.57% 19TCr
Average +3.14%+3.22%+37.92%+72.82% 44.31TCr
Weighted average by Cap. +1.85%+3.73%+43.01%+84.61%

Financials

2027 *2028 *
Net sales 1.4TCr 985.42Cr 878.1Cr 812.98Cr 735.72Cr 1.39TCr 93TCr 9.75TCr 3.82TCr 49TCr 3.7TCr 3.62TCr 1,55800Cr 1.46TCr 1.03TCr 916.57Cr 848.59Cr 767.95Cr 1.45TCr 97TCr 10TCr 3.99TCr 51TCr 3.86TCr 3.78TCr 1,62600Cr
Net income 23Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.51TCr 158.18Cr 62Cr 793.21Cr 60Cr 59Cr 2.53TCr 26Cr 19Cr 16Cr 15Cr 14Cr 26Cr 1.75TCr 183.01Cr 72Cr 917.7Cr 69Cr 68Cr 2.92TCr
Net Debt 101.29Cr 71Cr 63Cr 59Cr 53Cr 100.1Cr 6.72TCr 703.93Cr 276.21Cr 3.53TCr 266.96Cr 261.4Cr 11TCr 97Cr 68Cr 61Cr 56Cr 51Cr 96Cr 6.46TCr 677.17Cr 265.71Cr 3.4TCr 256.81Cr 251.46Cr 11TCr
Projected Income Statement - Annual - EBOS Group Limited
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - EBOS Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.09AUD
Average target price
23.31AUD
Spread / Average Target
+36.43%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EBOS Group Limited